Summary. A heavy chain component of yG-globulins in normal urines has the characteristics of the proteolytic digestion product, Fc-fragment. This fragment is estimated to compose up to 15% of the gamma globulins present in urines. In contrast to urinary light chains, the urinary Fc-like fragment probably represents a catabolic component in normal -yG-globulin metabolism.
Introduction
Urinary gamma globulins have been reported to include 7 S, 3.5 S, 2.0 S, and 1.2 S components (1) (2) (3) (4) (5) (6) (7) (8) . Among these components are free light chains as well as what appear to be intact 7 S yGglobulins. Urinary light chains are derived from the anabolic side of gamma globulin metabolism (5, 9) . A heavy (y) chain component has also been reported by Freedman and Connell (10) to be present in urines from normal persons immediately after heavy exercise, and Franklin, Lowenstein, Bigelow, and Meltzer (11) and Osserman and Takatsuki (12) have described abnormal y-chains in the urines of patients with "H chain disease." In Franklin's patient there was evidence to suggest that the y-chain component was an anabolic product in gamma globulin metabolism.
This report calls attention to the presence of a y-chain component in normal urines obtained from persons engaged in routine daily activities. This component has been shown to be indistinguishable from the Fc-fragment (13) obtained by proteolytic degradation of yG-globulin. From quantitative studies of the excretion of this Fc-like protein after therapeutic injection of yG-globulin into patients with agammaglobulinemia and from studies with leucine-14C incorporation or with yGglobulin-31 I degradation, we concluded that tlhe urinary Fc-like protein may normally come from yG-globulin catabolism. An estimate is also pro-266 vided of the relative quantities of various gamma globulin components in urine.
Methods
Urine collections and concentration. Twenty-fourhour urine samples were collected in toluene in a container kept at 4 to 100 C. Immediately thereafter 10 to 30 /g N of egg albumin was added for each 200 ml of urine as a quantitative marker, and the urines were transferred to dialysis bags, covered with chips of Carbowax,1 and allowed to concentrate in the cold about 200-fold. The concentrated samples were then dialyzed against 0.15 M NaCl to remove whatever Carbowax had diffused into the dialysis bag. Visking tubing with a 36/32-inch inflated diameter was used throughout. 2 Immunodiffusion and specific antisera. Estimations of the amounts of specific proteins in the urines were made by a micro-Oudin diffusion procedure (15) . Specific rabbit antisera were diluted in normal rabbit serum and mixed at 450 C with equal volumes of 0.6% agar in pH 7.3 phosphate-buffered saline and 0.01%o merthiolate.
Before they hardened, we added the antiserum solutions to 3-by 60-mm glass tubes, filling them halfway. The tubes were then sealed with small rubber caps and stored 1 Polyethylene glycol compound 20-M from the Union Carbide Chemical Co., New York, N. Y.
2A number of comparative studies were made with Visking 23/32 tubing, which can be obtained as Nojax 23 . This tubing has been shown to be impermeable to light chains in pressure filtration (14) , whereas other tubing was permeable. After concentrating by dialysis against Carbowax, however, we found no increased recovery of light chains in urines contained within the 23/32 tubing over that contained within the 36/32 tubing. in batches at 40 C. The following antisera were used: an antihuman serum albumin (anti-HSA); an anti-'yGglobulin containing antibodies to both heavy (y) and light chains; an anti-Bence Jones (anti-BJ) protein of Type K; an anti-Bence Jones protein of Type X; an anti-'y-chain immunoglobulin prepared by absorbing the anti--yG serum with light chains isolated after reductive cleavage (16) of Fraction II protein; an anti-Fd-fragment 3 made by absorbing the anti-y serum with Fc-fragment; and antiegg albumin (EA) serum. To assure specificity, the antisera to the gamma globulin components were fully absorbed with appropriate purified gamma globulins and with whole human sera specifically lacking the globulins in question,, as previously described (17) .
For determinations the tubes were removed from storage and the agar columns overlaid with the concentrated urine specimens or fractions. The tubes were recapped and kept in a constant temperature bath at 20.3 + 0.10 C.
The rates of descent of the precipitates in the agar were followed with a cathetometer and compared to those of antigen standards. Straight lines were obtained when the distances of the precipitates from the menisci were plotted against the square root of time, and the slopes of these lines were used to calculate the amounts of the antigens in the urine specimens. The concentration factors for the urines were estimated by comparison of the known amounts of egg albumin added originally to the urines with the amounts present in the concentrated specimens. Radioautography. Radiolabeled human yG-globulin was made from Fraction II protein (19) , and radiolabeled rabbit antibodies from rabbit gamma globulins precipitated from rabbit antisera by 33% ammonium sulfate. "1lIodine was used 4 in the method described by Helmkamp and co-workers (20) . After passage of the labeled preparations through Dowex 1-X-4 exchange resin and dialysis against 0. 15 of the 'yG-globulin and Fc-fragments used, i.e., to the chain serum as with the anti-yG serum, could be presence of aggregates oj IYG-alpbso preenc ofaggegaes f a-lobul"i to contaminating Attributed to whole -yG-globulins or to heavy chain 'yG-globulin in the Fc-fragmeitt preparation, or to suba types in the yG system (24, 25 (9) .
The amounts of yG-globulin calculated to be present from the diffusion studies were surprisingly high (last column). These calculated amounts would have suggested that more than half the urinary gamma globulin was intact (7 S) yG-globulin, but this conflicted with reports (1, 3, 5) which have indicated that no more than 5 to 10%o of the urinary gamma globulin is 7 S. It thus seemed likely that use of intact yG-globulin as the standard against which the diffusion values for urine against the anti-y-chain serum were calculated was incorrect, i.e., that 7 S yG-globulin was not the principal determinant of the leading edge of the band precipitating with the anti-y serum.
When urines were examined in varying concentrations against an anti-y serum, immunodiffusion coefficients were obtained for the urinary heavy (y) component as shown in Table II . Most urines gave one diffusing band,5 but some gave two. The coefficients for the heavy component were usually significantly higher (last column in the Table) than those of the yG-globulin standards, indicating that it was smaller than -yG-globulin. Two precipitin bands were seen in the urines on four occasions; on two of these occasions the extra (and slower) bands had coefficients that approximated those of the 7 S yG-globulin standards. In urine from a patient with orthostatic proteinuria, a single band, which diffused like 7 S -yG-globulin, was seen.
To determine whether the urinary heavy (y) chain component was in a molecule that also had light chains in it, we carried out radioifnmunodiffusion studies. Three different normal human urines were examined by Ouchterlony double diffusion analysis with an anti-y-chain serum and compared with Fc-and Fab-fragments (upper portion of Figure 2 ). As can be seen in the upper Figure, two lines of precipitation developed between each urine and the anti-y serum. The line closer to the antibody well was markedly concave 5 Urines that gave two or three distinct bands in double diffusion analysis with anti-y sera often exhibited only one or two bands in single diffusion. toward the well, as would be expected if the urinary component precipitating in this line was smaller than the 7 S rabbit antibody (27) . After the lines were fully developed, the slide was washed and all wells were filled with a 131I-labeled anti-BJ K preparation. Radioautography (lower portion of Figure 2) t Optical densities are calculated from the sums of the individual concentrations of a-globulins in each fraction in the quantitation diffusions of Figure 7 , using for comparison appropriate antigens with the standard antisera.
patterns obtained when these aliquots were examined after diffusion against anti-yG or anti-y sera. In each instance, comparison was made with the behavior of a control mixture of iodinated yG-globulin mixed with noniodinated light chains. Radioactivity did not appear in the light chain lines in Figure 4 (the inner lines nearer the antiserum well), nor in the line due to the heavy (y) chain fragment in Figure 5 . In both instances, only the line corresponding to whole yGglobulin appeared radioactive.6 Ultracentrifugal analyses in sucrose density gradients have been performed on urines from a number of patients and from normal persons. In Figure 6 are shown the results of one such study on concentrated pooled urine from male hospital employees. After centrifugation the fractions were examined in agar against specific antisera in single diffusion (quantitative) and double diffusion (qualitative) analyses. Precipitation was seen with anti-y serum in all regions from 7 to 6Although these data indicate no significant breakdown of -yG-globulin in the urine under the conditions employed, this may not hold for other conditions. In one experiment in our studies in which urines were dialyzed against acetic acid before analysis, all immunological evidence of the presence of 'y-globulins disappeared. The acid conditions of this experiment may have allowed activation of uropepsinogens (29 24 hours, the period during which maximal incorporation of the labeled amino acid into urinary gamma globulins occurs (9) . The urine sample was concentrated with Carbowax and passed through a DEAE cellulose column at 0.0175 M phosphate and pH 6.3. The gamma globulins thereby obtained (5, 9) were then submitted to sucrose density gradient ultracentrifugation; the pattern exhibited in Figure 7 was found. The tubes in the 4 to 7 S the 3 to 4 S, and the 2 to 3 S areas of the centrifuge run were pooled separately. To the pooled samples we added excesses of the rabbit anti-y serum to precipitate all protein containing heavy chain; to the supernatant we added anti-yG serum to precipitate the residual light chains. The precipitates were packed by centrifugation and then dissolved in 1 or 2 ml of Hyamine (9, 31) . The samples were added to 10 ml of PPO-POPOP [2,5- Ml.
FIG. 8. SPECIFIC RADIOACTIVITIES IN SEPHADEX FILTRATION FRACTIONS OF URINARY GAMMA GLOBULINS PREVIOUSLY ISOLATED BY PREPARATIVE DEAE CHROMATOGRAPHY.
There is significant radioactivity in the pool containing Fcfragment plus light chains but none in the pool containing light chains alone. Maximal radioactivity was seen in the pool containing -yG-globulin alone. The pools were constructed on the basis of their contents of gamma globulin components, as indicated by their immunodiffusion patterns with specific antisera. * A 48-year-old female; serum -yG was <10 mg per 100 ml. t A 39-year-old male; serum yG was <10 mg per 100 ml.
$ A 9-year-old male; serum -yG was 246 mg per 100 ml. This patient had been on -yG-globulin therapy; the last injection was given 8 days before this serum determination. § Immunodiffusion coefficient (X 10-3). :t Cti qzi III were found. Measurable radioactivity was completely restricted to samples containing free light chains. Thus, the urinary Fc-like protein, unlike urinary light chains (5, 9), could not be shown by this method of analysis to be an anabolic product of gamma globulin metabolism. The same patient was given an intravenous injection of yG-globulin labeled with 1.5 atoms 1311 per molecule. The urinary proteins were collected over a 3-day period and the collections were pooled. The gamma globulins were separated by DEAE chromatography and filtered through Sephadex G-100 (Figure 8 ). After preliminary identification of the location of the various gamma globulin components in the effluents by Ouchterlony analysis, pools were made, concentrated, and divided for counting and for analysis by sucrose density gradient ultracentrifugation. The latter confirmed the distributions of gamma globulin components indicated by the initial Ouchterlony analyses and illustrated in the Figure. The highest counts of radioactivity were identified in the pools (8-11 and 12-21) containing yG-globulins. Lesser but significant counts were found in the region containing the Fc-like fragment and light chains (pool [22] [23] [24] [25] [26] , whereas the pool (27) (28) (29) (30) (31) (32) (33) (34) (35) containing only light chains was free of counts. The results confirmed, reciprocally, those obtained with leucine-14C (cf. also 5, 9) .
Three patients with severe hypogammaglobulinemia were examined before and after administration of therapeutic amounts of yG-globulin (0.1 g per kg body weight). The urinary gamma globulins measurable in 24-hour specimens before and after the injections are indicated in Table IV Table I ). A sucrose density gradient ultracentrifugation of a post-treatment urine from L.P. is illustrated in Figure 9 . Very little 7 S yGglobulin appeared to be present in this specimen.
There was a slight increase in the quantities of light chains in the post-treatment urines in all SUCROSE DENSITY GRADIENT (5-20l (5) and by Gordon, Eisen, and Vaughan (9) that light chains of the urine are derived, at least predominantly, from an anabolic phase in gamma globulin metabolism. The current data indicate that an Fc-like fragment is also present in normal urine, a finding that has recently been reported independently by Turner and Rowe (32) . The evidence to support belief that this Fc-like fragment is a catabolic rather than an anabolic product of serum yG-globulin metabolism is impressive, though perhaps still somewhat incomplete. Failure of leucine-14C to appear in the urinary Fc-like protein during the first 24 hours after its parenteral administration (Table III) may be better interpreted in terms of the longer persistence of Fc in the circulation and the lesser rate of its delivery to the urine, as compared with light chains (5, 9, 33, 34) . On the other hand, parenterally administered yG-globulin gave rise to Fc-fragment in the urine in several studies ( Figure 8 and Table IV) . It may be argued that the purified yG-globulin (Fraction II) used for the parenteral administrations in these studies was not normal, since it had been exposed to various denaturing influences during its isolation and therefore was unusually 276 susceptible to the host's catabolic systems. By the same token, the Fc-like component normally present in urines may be an excretion product from autologously denatured yG-globulin.
The Fc-like component normally present in urine resembles in some respects the component described by Franklin and associates (11) and Osserman and Takatsuki (12) in patients with "H chain disease." Franklin and associates (11) suggested that the y-chain component in "H chain disease" may be derived from the anabolic side of 'yG-globulin metabolism, but the studies they offered in support of this were limited. The strongest evidence presented was the rate of elimination of injected radioactively labeled normal yG-globulin. Failure of the label to appear in large quantity in the urine of their patient, who was excreting large amounts of the abnormal y-chain component, was rightly taken to indicate that normal serum yG-globulin was not a source for the urinary protein. Their data did not, however, indicate that the urinary protein could not have been a product of degradation of abnormal quantities of free heavy chains in the tissues before they reached the circulation.
The suggestion in the present findings that urinary Fc-like fragment normally derives from catabolism of yG-globulin is significant in relation to current theories of yG-globulin structure. The six chain theory (35, 36) has been derived in part from Franklin's observations on the supposed anabolic nature of the urinary product in heavy chain disease. This interpretation and the theoretical extrapolation from it seem worthy of reappraisal.
The sedimentation coefficient for normal urinary Fc-like fragment could be estimated from the sucrose density gradient ultracentrifugation data by the method of Martin and Ames (37 (33) found that the tj of labeled Fab injected intravenously in man was extremely short, whereas that of intravenously injected Fc-fragment was quite long. Spiegelberg and Weigle (34) made similar observations in animals and noted that radioactively labeled F(ab')2 (5 S) derived from pepsin digestion behaved similarly to Fab (3.5 S) derived fram papain digestion. The label from Fab or F(ab')2 appeared in the urine, furthermore, largely in a form nonprecipitable with TCA. It Tables I and IV) may represent only 5 to 20% of the total Fc product passing from the blood into the urine.
Several features about the urinary gamma globulin components in the three patients with agammaglobulinemia are of interest. First, although each of these individuals had comparable degrees of hypogammaglobulinemia, only in the child with congenital agammaglobulinemia were urinary light chains completely undetectable. The two adult patients had easily measured urinary light chain levels. These were only about one-tenth the normal average (cf. Table I ), whereas the serum gamma globulin levels were less' than one-hundredth the normal level. It seems possible, therefore, that the deficit in -yG-globulin production in the adults may be more closely related to impairment of heavy chain than light chain production.
The amount of Fc-like fragment that appeared in the urine of the agammaglobulinemic patients after treatment was greater in proportion to the serum levels of gamma globulin than one would expect from the urinary values in normal individuals (Table I ). This suggests that in the treated agammaglobulinemic individual there may be a more rapid than normal breakdown of the injected gamma globulin. The measured halflife of the injected yG-globulin in the serum of each of the agammaglobulinemic patients was normal or prolonged. It seems reasonable to assume that there may be breakdown of the gamma globulin at the sites of injection in the interstitial tissues by proteolytic processes called into play in response to the abnormal quantity of protein deposited there.
